New patent for Actelion Pharms drug OPSUMIT

Annual Drug Patent Expirations for OPSUMIT Opsumit is a drug marketed by Actelion Pharms Ltd and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Actelion Pharms drug OPSUMIT appeared first on DrugPaten…


New patent for Astrazeneca Ab drug BYDUREON PEN

Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared fi…


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog